AbbVie Inc. (ABBV)

Patterson Companies Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Immunology	27.58B	26.68B	26.34B	26.08B	25.92B	26.14B	27.11B	27.98B
Immunology Growth	6.39%	2.09%	-2.83%	-6.78%	-8.64%	-9.64%	-2.30%	4.51%
Neuroscience	9.32B	9.00B	8.58B	8.26B	7.99B	7.72B	7.33B	6.96B
Neuroscience Growth	16.64%	16.61%	17.06%	18.70%	18.59%	18.21%	13.30%	9.36%
Hematologic Oncology	6.65B	6.56B	6.37B	6.20B	6.04B	5.92B	6.04B	6.18B
Hematologic Oncology Growth	9.98%	10.82%	5.57%	0.37%	-4.81%	-10.07%	-11.47%	-12.22%
Aesthetics	5.03B	5.18B	5.25B	5.25B	5.24B	5.29B	5.21B	5.27B
Aesthetics Growth	-4.08%	-2.23%	0.75%	-0.44%	-0.30%	-0.73%	-4.46%	-2.42%
Other Products	3.56B	3.65B	3.70B	3.79B	3.78B	3.81B	3.82B	3.85B
Other Products Growth	-5.85%	-4.15%	-3.14%	-1.51%	-2.50%	-1.25%	-11.01%	-17.57%
Eye Care	2.21B	2.24B	2.18B	2.26B	2.35B	2.42B	2.42B	2.44B
Eye Care Growth	-5.76%	-7.16%	-9.88%	-7.26%	-7.60%	-10.59%	-21.20%	-26.54%

Revenue by Geography

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
US	43.97B	43.03B	42.41B	42.11B	41.72B	41.88B	42.97B	43.88B
US Growth	5.38%	2.74%	-1.30%	-4.03%	-6.38%	-8.38%	-4.94%	-1.87%
International	13.40B	13.31B	13.13B	12.89B	12.68B	12.44B	12.17B	12.15B
International Growth	5.68%	7.00%	7.85%	6.12%	4.15%	0.76%	-3.55%	-3.86%

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018
Selling, General, and Administrative	14.73B	14.75B	14.09B	13.26B	13.15B	12.87B	13.10B	13.03B
Selling, General, and Administrative Growth	12.03%	14.61%	7.59%	1.76%	-13.34%	-15.65%	-13.29%	-12.46%
Research and Development	12.92B	12.79B	7.94B	7.54B	7.32B	7.68B	7.54B	7.43B
Research and Development Growth	76.44%	66.66%	5.39%	1.45%	0.23%	17.90%	15.14%	12.66%
Acquired In-Process R&D	2.84B	2.76B	1.47B	1.45B	792.00M	778.00M	739.00M	713.00M
Acquired In-Process R&D Growth	258.71%	254.37%	98.24%	103.23%	12.82%	11.62%	-13.97%	-41.61%
Other	-	-7.00M	-	-	-	-	-	49.00M
Other Growth	-	-	-	-	-	-	-	-85.06%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.